Results 131 to 140 of about 3,281,120 (365)
Antithrombin: Deficiency, Diversity, and the Future of Diagnostics
ABSTRACT Our healthcare system provides reactive sick‐care, treating patients after symptoms have appeared by prescription of generic and often suboptimal therapy. This strategy brings along high costs and high pressure which is not sustainable.
Mirjam Kruijt+2 more
wiley +1 more source
This study aims to investigate the effect of antipsychotic agents on cardiovascular and cerebrovascular diseases (CVD/CEV) and mortality risks in the older population living in a community.
Sylvie Perreault+4 more
doaj +1 more source
Influence of Antipsychotic Agents on the Sexuality of Patients Diagnosed with Schizophrenia. [PDF]
Fares J+5 more
europepmc +1 more source
Safety and Effect of 12‐Month Ecopipam Treatment in Pediatric Patients with Tourette Syndrome
Abstract Background Tourette syndrome (TS) is a chronic neurodevelopmental tic disorder with a considerable quality of life (QOL) burden. Objectives The goal was to determine the long‐term safety, tolerability, and clinical effects of ecopipam, a first‐in‐class dopamine D1 receptor antagonist, for TS.
Donald L. Gilbert+7 more
wiley +1 more source
Background: Unintentional pediatric poisoning with antipsychotic medications represents an important clinical entity. This study aimed to evaluate the epidemiology, clinical manifestations, and outcomes of antipsychotic poisoning among children ...
Fariba Farnaghi+2 more
doaj +1 more source
Purpose: The objective of this study was to document the prevalence of high blood pressure (BP) and to explore its relationship with weight among inpatients with schizophrenia.
Yu-Li Lan, PhD, Tzy-Ling Chen, PhD
doaj +1 more source
Patient and Healthcare Professional Preferences for Characteristics of Long-Acting Injectable Antipsychotic Agents for the Treatment of Schizophrenia. [PDF]
Robinson DG+7 more
europepmc +1 more source
Correction: Clozapine, a Novel Antipsychotic Agent [PDF]
Olga Delgado Sánchez+1 more
openalex +1 more source
Abstract Background The coexistence of tics with Parkinson's disease (PD) is rare, as they often emerge at different ages, follow different trajectories and involve contrasting pathophysiological mechanisms related to dopamine availability and function in the brain. Cases We present 10 individuals with primary tic disorders who later developed PD.
Tarig Abkur+11 more
wiley +1 more source
Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents. [PDF]
Kannarkat GT, Caroff SN, Morley JF.
europepmc +1 more source